What defined pharma in 2025? Contract Pharma’s most‑viewed breaking news offers insights. Here’s your yearly recap—the most ...

U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs ...

Millions in the U.S. struggle with high prescription costs, even with insurance. Recent agreements between the federal ...

The agreement will lower the cost of certain drugs for asthma, some cancers, HIV and Type 2 diabetes, among other conditions.

What Happened? Shares of biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) jumped 2.6% in the afternoon session after the stock's positive momentum continued as the company agreed to acquire ...

Large pharmaceutical companies are entering a period of renewed relevance as therapeutic innovation accelerates, particularly ...

Under the deals, each drugmaker will cut prices on most drugs sold to the Medicaid program for low-income people, senior ...

For more than five years, pharma companies and PBMs have managed to avoid disclosing the actual prices of prescription drugs.

Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to drug pricing deals.

Investors are currently so focused on one type of drug that even good companies are being left on the sidelines.

When patent protection on drugs ends, however, companies face generic competition, as competitors such as Teva make copies of ...

Discover how drugs prevent, cure, and alleviate ailments. Learn about over-the-counter vs. prescription drugs and the ...